Northstar Asset Management LLC Novo Cure LTD Transaction History

Northstar Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$56.6 - $89.9 $660,239 - $1.05 Million	-11,665 Closed	0 $0
Q1 2022 Apr 26, 2022	SELL	$60.15 - $84.52 $236,088 - $331,741	-3,925 Reduced 25.18%	11,665 $967,000
Q4 2021 Feb 03, 2022	SELL	$75.08 - $121.99 $44,297 - $71,974	-590 Reduced 3.65%	15,590 $1.17 Million
Q2 2021 Aug 11, 2021	BUY	$130.4 - $225.58 $14,344 - $24,813	110 Added 0.68%	16,180 $3.59 Million
Q1 2021 Apr 21, 2021	SELL	$124.11 - $190.17 $102,390 - $156,890	-825 Reduced 4.88%	16,070 $2.12 Million
Q4 2020 Jan 21, 2021	SELL	$112.16 - $174.14 $23,553 - $36,569	-210 Reduced 1.23%	16,895 $2.92 Million
Q3 2020 Oct 19, 2020	BUY	$58.05 - $111.31 $4,353 - $8,348	75 Added 0.44%	17,105 $1.9 Million
Q2 2020 Aug 03, 2020	BUY	$57.2 - $74.41 $974,116 - $1.27 Million	17,030 New	17,030 $1.01 Million

266

78M

970K

118K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.85B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Northstar Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Northstar Asset Management LLC with notifications on news.